Revolution Medicines, Inc. Warrant (RVMDW)
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Revolution Medicines, Inc. Warrant (RVMDW) is listed on Nasdaq, where it has traded since November 17, 2023.
- Listed On
- Nasdaq
- Listed Since
- November 17, 2023
- Employees
- 883
About Revolution Medicines, Inc. Warrant
Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 22 institutions reported holding RVMDW, with 10.1 million shares worth $104.3 million in aggregate. The largest reported holder was Lmr Partners, with 5.1 million shares worth $47.5 million. Of the 5 largest holders listed below, 1 added shares, 1 reduced its position and 3 held their positions unchanged during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| Lmr Partners | 5,066,598 | $48M | Added 32.01% |
| D. E. Shaw | 1,580,345 | $15M | Unchanged |
| Sculptor Capital | 709,670 | $7M | Reduced 25.99% |
| T. Rowe Price | 579,550 | $5M | Unchanged |
| Caption Management | 517,685 | $5M | Unchanged |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is RVMDW?
Revolution Medicines, Inc. Warrant (RVMDW) is listed on Nasdaq, where it has traded since November 17, 2023.
Who are the largest institutional holders of RVMDW?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of RVMDW were Lmr Partners, D. E. Shaw and Sculptor Capital.
How many institutions own RVMDW?
22 institutions reported a position in RVMDW for the quarter ended June 30, 2026, worth $104.3 million in total.
Did institutions buy or sell RVMDW last quarter?
Of the 5 largest reported holders, 1 added shares, 1 reduced its position and 3 held their positions unchanged during the quarter. Every reported holder and its change is on the SentiSense ownership page for RVMDW.
Every reported institutional holder, plus insider and congressional trades in RVMDW, on SentiSense.